Turmeric and Boswellia Combination Shows Significant Efficacy in Osteoarthritis Management

Strategic Insights -

Research from India has revealed that a natural combination of turmeric and boswellia extracts, formulated in a product called Rhuleave-K, demonstrates significant anti-inflammatory effects and improves symptoms of mild-to-moderate osteoarthritis (OA). The study, published in Pharmacognosy Magazine, involved 100 participants who received either Rhuleave-K or a placebo for 12 weeks, with the primary outcome being the change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores.

Key Takeaways:

  • The study found that the combination of turmeric and boswellia extracts showed a significant improvement in the total WOMAC score of 55% after 12 weeks.
  • The improvement was observed as early as 6 weeks, suggesting that the combination may be a safe and suitable addition to current OA management.
  • The participants who received Rhuleave-K showed a significant reduction in pain intensity, with 55% of them experiencing a decrease in pain ratings on the Numerical Rating Scale (NRS).
  • The study's secondary outcomes included Osteoarthritis Research Society International (OARSI) battery tests and NRS scores, which showed a significant improvement in the test group.
  • The Rhuleave-K formulation was found to be safe, with no adverse effects reported by the participants.
  • The study was conducted by investigators from the Department of Orthopedics, Nirmal Hosp, Jhansi, Uttar Pradesh, India.

Statistics:

  • 100 participants with mild-to-moderate OA symptoms (Kellgren-Lawrence (KL) grade 2-3) and pain intensity 5 on the NRS were enrolled in the study.
  • Participants received either 500 mg of Rhuleave-K soft gel capsules (turmeric extract, boswellia extract, and sesame oil as key components) or a matching placebo once daily for 12 weeks.
  • The primary outcome was the change in WOMAC scores at the end of the study, with a significant improvement observed in the test group.
  • The study showed a significant reduction in pain intensity, with 55% of the participants experiencing a decrease in pain ratings on the NRS.
  • The OARSI battery tests and NRS scores also showed a significant improvement in the test group.

Sources:

  • "Study Results from Department of Orthopedics Update Understanding of Osteoarthritis (A Randomized Double-blinded Placebo-controlled Study To Determine the Efficacy of Rhuleave-k On Subjects With Mild To Moderate Osteoarthritis)" - NewsRx
  • A Randomized Double-blinded Placebo-controlled Study To Determine the Efficacy of Rhuleave-k On Subjects With Mild To Moderate Osteoarthritis. Pharmacognosy Magazine, 2025.